What Is SS-31?
SS-31 research represents one of the most targeted and mechanistically precise approaches in mitochondrial biology, with this synthetic Szeto-Schiller tetrapeptide demonstrating selective concentration in the inner mitochondrial membrane and potent cardioprotective, cytoprotective, and anti-aging effects in preclinical and early clinical research.
SS-31 (D-Arg-Dmt-Lys-Phe-NH2, molecular weight approximately 640 Da) — also known as Elamipretide or MTP-131 — is a member of the Szeto-Schiller (SS) peptide family, developed by Hazel Szeto at Cornell University. The peptide was rationally designed to selectively target and concentrate in the inner mitochondrial membrane (IMM) at a concentration approximately 1,000-fold higher than cytoplasmic levels, where it interacts with cardiolipin — an anionic phospholipid uniquely expressed in the IMM and critically important for mitochondrial architecture and function. This remarkable mitochondrial targeting specificity, achieved through the peptide’s alternating aromatic and basic residue pattern, allows SS-31 to act directly at the site of mitochondrial dysfunction — a location that most antioxidants and cytoprotective compounds cannot efficiently reach.
Mechanism of Action
Cardiolipin Interaction and Stabilization
Cardiolipin is a unique dimeric phospholipid exclusively expressed in the IMM, where it plays essential structural and functional roles: maintaining IMM curvature at cristae junctions, organizing electron transport chain (ETC) supercomplexes (respirasomes), stabilizing ATP synthase oligomers, and serving as a binding platform for numerous IMM proteins involved in apoptosis and mitophagy. Cardiolipin is exquisitely sensitive to oxidative damage — peroxidation of cardiolipin’s four polyunsaturated fatty acid chains disrupts all of its structural functions simultaneously. SS-31 binds directly to cardiolipin through electrostatic and hydrophobic interactions, physically protecting it from peroxidation and maintaining its structural integrity under oxidative stress conditions.
Electron Transport Chain Optimization
By stabilizing cardiolipin — which is required for the assembly and stability of ETC supercomplexes — SS-31 preserves the efficiency of mitochondrial electron transport and reduces electron leak to oxygen that would otherwise generate superoxide. This reduction in mitochondrial ROS production at the source — rather than scavenging ROS after they have already been generated — is mechanistically distinct from conventional antioxidants and represents a fundamentally different approach to oxidative stress research. Research has documented improvements in Complex I, II, and III activity following SS-31 treatment in models of mitochondrial dysfunction.
Mitochondrial Membrane Potential Preservation
The mitochondrial membrane potential (ΔΨm) — maintained by proton pumping across the IMM — is the driving force for ATP synthesis and a critical indicator of mitochondrial health. Cardiolipin peroxidation and ETC dysfunction both contribute to ΔΨm collapse under stress conditions. Research has demonstrated that SS-31 treatment preserves ΔΨm under ischemic, oxidative, and cytotoxic stress conditions — maintaining the energetic capacity of stressed cells and reducing the threshold for mitochondrial permeability transition pore (mPTP) opening.
Mitochondrial Permeability Transition Pore Prevention
The mPTP is a non-selective channel in the IMM that opens under conditions of oxidative stress, calcium overload, and ΔΨm collapse — releasing cytochrome c and other pro-apoptotic factors and triggering cell death. mPTP opening is a key event in ischemia-reperfusion injury, neurodegeneration, and heart failure. By preserving cardiolipin integrity and ΔΨm, SS-31 reduces the probability of mPTP opening under stress conditions — a mechanism directly relevant to cardioprotection and neuroprotection research.
Cristae Remodeling and ATP Synthase Support
Cardiolipin stabilizes the tight membrane curvature at cristae junctions — the folded inner membrane structures that maximize ETC surface area — and directly supports ATP synthase oligomerization, which is required for the enzyme’s full rotary catalysis efficiency. Research has shown that SS-31 treatment can restore cristae morphology and ATP synthase activity in models of mitochondrial dysfunction, improving both the structural architecture and the bioenergetic output of dysfunctional mitochondria.
Research Applications
Cardiac Ischemia-Reperfusion Research
The most extensively studied application for SS-31 concerns cardiac ischemia-reperfusion (I/R) injury — the paradoxical tissue damage that occurs when blood flow is restored to an ischemic heart. Reperfusion triggers a burst of mitochondrial ROS production, calcium overload, and mPTP opening that kills cardiomyocytes that survived the ischemic period. Research has examined SS-31’s ability to reduce infarct size, preserve cardiac function, and attenuate cardiomyocyte death in I/R models by maintaining mitochondrial integrity during the reperfusion burst — with results that have been sufficiently compelling to advance it to human clinical investigation (Elamipretide) for heart failure.
Heart Failure Research
Chronic heart failure is characterized by progressive cardiomyocyte mitochondrial dysfunction, including reduced ETC activity, impaired ATP production, increased oxidative stress, and cristae ultrastructural abnormalities. Research has examined SS-31’s ability to restore mitochondrial function and improve cardiac performance in pressure overload and post-infarction heart failure models, with clinical studies (PROGRESS-HF, LEAF-HF) examining its effects on cardiac energetics and function in human heart failure patients.
Age-Related Mitochondrial Dysfunction Research
Mitochondrial dysfunction — characterized by reduced ETC efficiency, increased ROS production, impaired mitophagy, and cardiolipin peroxidation — is one of the most fundamental hallmarks of biological aging across tissues. Research has examined SS-31 in aged animal models, demonstrating improvements in mitochondrial function, physical performance, and multiple biomarkers of mitochondrial aging following treatment. Its ability to act directly at the IMM makes it a particularly relevant tool for studying the mechanistic relationship between cardiolipin integrity, mitochondrial function, and biological aging.
Skeletal Muscle and Exercise Research
Skeletal muscle mitochondrial density and function decline significantly with aging (sarcopenia) and disuse. Research has examined SS-31’s effects on skeletal muscle mitochondrial function, exercise capacity, and markers of muscle atrophy in aged and disuse atrophy models — investigating whether IMM-targeted cytoprotection can preserve mitochondrial function in metabolically active tissues.
Renal and Neurological Research
Kidney tubular cells and neurons are among the most mitochondria-dependent cell types in the body, and both are highly vulnerable to ischemic and oxidative injury. Research has examined SS-31’s cytoprotective effects in models of acute kidney injury, chronic kidney disease, and neurodegeneration — extending the mechanistic framework established in cardiac research to other high-energy-demand tissues.
SS-31 in the AminoForge Mitochondrial and Longevity Research Catalog
SS-31 is among the most mechanistically specific mitochondria-targeted research compounds available. At AminoForge, researchers investigating mitochondrial biology and aging may find it most productive when studied alongside complementary mitochondrial and longevity compounds: MOTS-C — a mitochondria-derived peptide that activates AMPK and drives metabolic adaptation through nuclear signaling — and NAD+, which supports ETC function through NADH supply and activates sirtuin-mediated mitochondrial biogenesis through SIRT1/SIRT3. For cardiac and vascular aging research, GHK-Cu offers complementary extracellular matrix and anti-inflammatory mechanisms in cardiovascular tissue. For further reading see: SS-31 mitochondrial targeting and cardioprotection (PubMed).
Shop SS-31 at AminoForge — ≥99% purity, third-party COA verified, USA manufactured, ships within 48 hours.
Formulation and Storage
SS-31 is available as a lyophilized powder. With a molecular weight of approximately 640 Da and a D-amino acid backbone that confers resistance to proteolytic degradation, SS-31 is relatively stable compared to L-amino acid peptides of similar size. Standard storage at −20°C for lyophilized powder applies, with reconstituted solutions stored at 2–8°C and protected from light. Bacteriostatic water is the standard reconstitution vehicle. Research-grade purity should be verified at ≥99% by HPLC with mass spectrometry confirmation of the correct molecular weight and D-amino acid configuration.
All products sold by AminoForge are intended exclusively for laboratory and research purposes. Not for human or veterinary consumption. Researchers are responsible for compliance with all applicable laws and regulations governing research compound use in their jurisdiction.